← Leaderboards
Margaret K-H Yu
University Of Utah
$118,032
Attributed
$118,032
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $70.8K · FY2005–08$100K$75K$50K$25K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$118,032 · 6
By mechanism
M01$118,032 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- William L. Carroll$23,653,738
- Mary C. Beckerle$16,693,203
- Jonathan Michael Dean$100,798,669
- Kathleen H Mooney$23,401,107
- Bradley R Cairns$10,773,002
Others in their field
Top investigators on “Vidaza”
- Steven A Belinsky · Lovelace Biomedical &Environmental Res$1,980,421
- Philip Kuehl · Lovelace Biomedical & Environmental Research Institute$1,980,421
- Anthony G Letai · Dana-Farber Cancer Inst$1,923,111
- Haiching Ma · University Of Pennsylvania$1,373,953
- Gregory Joseph Riggins · Johns Hopkins University$1,111,725
- Stephen B Baylin · Johns Hopkins University$709,265
Research focus
VidazaChronic Lymphocytic LeukemiaComputer Retrieval Of Information On Scientific Projects DatabaseDna MethylationDysmyelopoietic SyndromesFundingGrantInhibitor/AntagonistInstitutionMalignant NeoplasmsResearch PersonnelResourcesSourceTumor Suppressor GenesUnited States National Institutes Of HealthClinical Trials
Grant awards (6)
CLINICAL TRIAL: CHRONIC LYMPHOCYTIC LEUKEMIA$5,330
M01 · FY2008 · RR · contact PI
CHRONIC LYMPHOCYTIC LEUKEMIA$33,949
M01 · FY2007 · RR · contact PI
CLADRIBINE AS A DNA METHYLATION INHIBITOR IN CHRONIC LYMPHOCYTIC LEUKEMIA$49,964
M01 · FY2006 · RR · contact PI
PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA$20,819
M01 · FY2006 · RR · contact PI
CLADRIBINE AS A DNA METHYLATION INHIBITOR IN CHRONIC LYMPHOCYTIC LEUKEMIA$7,551
M01 · FY2005 · RR
OPTIMIZING GROWTH CONDITIONS FOR HAIRY CELL LEUKEMIA-A PRELIMINARY STUDY$419
M01 · FY2005 · RR